Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02635360
Title Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Linda R Duska
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604 United States Details
Johns Hopkins Baltimore Maryland 21287 United States Details
Washington University, School of Medicine Saint Louis Missouri 63108 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
INOVA Fairfax Hospital Falls Church Virginia 22042 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field